Skip to content

The Relationship Between ALDH2 and Aortic Dissection

The Relationship Between ALDH2 and Aortic Dissection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02630212
Acronym
RALAD
Enrollment
400
Registered
2015-12-15
Start date
2015-12-31
Completion date
2019-12-31
Last updated
2019-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Dissection

Keywords

Aortic dissection, Aldehyde dehydrogenase 2 polymorphism, Risk factor, aldehyde dehydrogenase 2

Brief summary

The purpose of this study is to evaluate the impact of ALDH2 Glu504Lys polymorphism on aortic dissection.

Interventions

None listed

Sponsors

Qilu Hospital of Shandong University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Chinese Han people diagnosed with aortic dissection in Qilu Hospital

Exclusion criteria

* Aortic dissection based on trauma, connective tissue diseases and pregnancy * Patients with tumor * Patients with no written consensus

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with different ALDH2 genotype1-30 days after samples collectedDNA was extracted from venous blood;genomic DNA underwent PCR amplification; finally, PCR products were purified and directly sequenced by Invitrogen Corp or Biosune Corp.Then ALDH2 genotype was distinguished depend on a G-to-A missense mutation on exon 12 of ALDH2 gene.

Secondary

MeasureTime frameDescription
Concentration of inflammatory factors in blood and aortic specimen1-30 days after samples collectedConcentration of 4-HNE、MMP-2、MMP-9 detected by elisa kit、IHC or western blot in relevant specimen.
ALDH2 activity1-30 days after samples collectedActivity of ALDH2 was detected in blood and aortic specimen depend on its reducibility of NAD+

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026